Trial Profile
Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Fondaparinux sodium (Primary) ; Dalteparin sodium; Enoxaparin sodium; Heparin
- Indications Venous thromboembolism
- Focus Therapeutic Use
- Sponsors GSK
- 05 Oct 2011 New trial record